Flavio Mozzani

Flavio Mozzani

Auto-generated profile, based on publicly available information

Flavio Mozzani

Internal Medicine and Rheumatology Unit, University Hospital of Parma, Parma, Italy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2009 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
VPVladimiro Pietrini
Vladimiro Pietrini
FMFlavio Mozzani
Flavio Mozzani
PCPellegrino Crafa
Pellegrino Crafa
RSRoberto Sivelli
Roberto Sivelli
Filippo CademartiriFilippo Cademartiri
Filippo Cademartiri
GCGirolamo Crisi
Girolamo Crisi

8 November 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PGPablo Guisado-Vasco
Pablo Guisado-Vasco
MSMario Silva
Mario Silva
MMMiguel Angel Duarte Millan
Miguel Angel Duarte Millan
Gianluca SambataroGianluca Sambataro
Gianluca Sambataro
CBChiara Bertolazzi
Chiara Bertolazzi
AAAlarico Ariani
Alarico Ariani
Interstitial lung disease (ILD) is a frequent manifestation of Sjögren’s syndrome (SS), an autoimmune disease of salivary and lacrimal glands, and affects approximately 20% of patients. No clinical or serological features appear to be useful to predict its presence, severity or progression, and chest high-resolution computed tomography (CT) remains the gold standard for diagnosis. Semiquantitative CT (SQCT) based on visual assessment (Goh and Taouli scoring) can estimate ILD extent, although it is burdened by relevant intra- and interobserver variability. Quantitative chest CT (QCT) is a promising alternative modality to assess ILD severity. To determine whether QCT assessment can identify extensive or limited lung disease in patients with SS and ILD. This multi-center, cross-sectional and retrospective study enrolled patients with SS and a chest CT scan. SQCT assessment was carried out in a blinded and centralized manner to calculate both Goh and Taouli scores. An operator-independent analysis of all CT scans with the open-source software platform Horos was used to evaluate the QCT indices. Patients were classified according to the extent of ILD and differences in QCT index distribution were investigated with non-parametric tests. From a total of 102 consecutive patients with SS, the prevalence of ILD was 35.3% (36/102). There was a statistically significant difference in QCT index distribution between the SS with ILD and SS without ILD groups (p20% (by Goh score) had a QCT index statistically different from those with limited ILD extent (p<0.001). Finally, QCT indices showed a moderate-to-good correlation with the Goh and Taouli scores (from 0.44 to 0.65; p<0.001). QCT indices can identify patients with SS and ILD and discriminate those with lesser or greater lung disease.

5 July 2010 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
WSWalter Serra
Walter Serra
Alfredo ChettaAlfredo Chetta
Alfredo Chetta
DSDaniele Santilli
Daniele Santilli
FMFlavio Mozzani
Flavio Mozzani
PDPier Paolo Dall'AGlio
Pier Paolo Dall'AGlio
TGTiziano Gherli
Tiziano Gherli
Pulmonary arterial hypertension (PAH) in patients with systemic sclerosis is associated with a poor prognosis, but this can be improved by early disease detection. Abnormal pulmonary and cardiac function can be detected early by means of echocardiography, whereas right heart catheterization is usually performed later.

7 July 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
AAAlarico Ariani
Alarico Ariani
Simone ParisiSimone Parisi
Simone Parisi
PMPatrizia Del Medico
Patrizia Del Medico
AFantonella farina
antonella farina
EVElisa Visalli
Elisa Visalli
ABAndrea Becciolini
Andrea Becciolini

1 April 2021 in European Journal of Rheumatology
Verified
Journal Article
Open access
ABAndrea Becciolini
Andrea Becciolini
FLFederica Lumetti
Federica Lumetti
EDEleonora Di Donato
Eleonora Di Donato
SGSalvatore Giordano
Salvatore Giordano
DSDaniele Santilli
Daniele Santilli
AAAlarico Ariani
Alarico Ariani
Cite this article as: Becciolini A, Lumetti F, Di Donato E, Giordano S, Santilli D, Mozzani F, et al. bDMARDs retention rate in the biosimilar era: a real-life monocentric study. Eur J Rheumatol 2021; 8(2): 109-10.